pharma · Contraception · Chlamydia Trachomatis Infection · EVFM
Evofem Biosciences
Evofem Biosciences clinical programs — 6 development programs from ClinicalTrials.gov with phase, modality, indication, and trial identifiers.
Company details
- Status
- Public
- HQ
- San Diego, USA
- Founded
- 2015
- Employees
- 39
- Programs
- 6
- Drugs
- 2
- Patents
- 8
Evofem Biosciences projects
6 ClinicalTrials.gov programs sponsored by Evofem Biosciences.
Evofem Biosciences has 6 clinical development programs indexed from ClinicalTrials.gov, including phase, modality, indication text, and linked NCT identifiers.
Clinical programs
-
AMPHORA
Evofem Biosciences
Contraception
1 trial -
Conceptrol
Evofem Biosciences
Contraception
1 trial -
EVO100
Evofem Biosciences
Chlamydia Trachomatis Infection
1 trial -
EVO100
Evofem Biosciences
Sexually Transmitted Diseases
1 trial -
LIPO-202
Evofem Biosciences
Central Abdominal Bulging
2 trials -
Acidform 5 g
Evofem Biosciences
Healthy
1 trial
Frequently asked questions
How many clinical projects does Evofem Biosciences have?
6 published programs are linked to this sponsor in our ClinicalTrials.gov index.
Is this the complete company pipeline?
This directory lists published programs for the sponsor in our database. Partnered or out-licensed assets may appear under multiple companies.